Diastereoselective Synthesis of Substituted 4-Piperidones and 4-Piperidols Using a Double Mannich Reaction

Abstract

A simple and efficient synthesis of polysubstituted 4-piperidones was achieved from the double Mannich reaction of β-keto esters and bisaminol ethers. The reaction is highly diastereoselective, as is the subsequent hydride reduction, to give polysubstituted 4-piperidols.

4-piperidones - Mannich reaction - multicomponent reaction

References and Notes

<A NAME="RD27908ST-1A">1a</A> Watson PS. Jiang B. Scott B. Org. Lett.  2000,  2:  3679 

<A NAME="RD27908ST-1B">1b</A> Danieli B. Lesma G. Passarella D. Silvani A. Tetrahedron Lett.  2000,  41:  3489 

<A NAME="RD27908ST-1C">1c</A> Danieli B. Lesma G. Passarella D. Silvani A. J. Org. Chem.  1998,  63:  3492 

<A NAME="RD27908ST-1D">1d</A> Davis FA. Chao B. Rao A. Org. Lett.  2001,  3:  3169 

<A NAME="RD27908ST-2A">2a</A> Manske RH. Can. J. Res.  1938,  16B:  57 

<A NAME="RD27908ST-2B">2b</A> Goodson JA. J. Chem. Soc.  1943,  139 

<A NAME="RD27908ST-2C">2c</A> Yunusov MS. Nat. Prod. Rep.  1993,  10:  471 

<A NAME="RD27908ST-2D">2d</A> Hardick DJ. Blagbrough IS. Cooper G. Potter BVL. Critchley T. Wonnacott S. J. Med. Chem.  1996,  39:  4860 

<A NAME="RD27908ST-3A">3a</A> Goodall KJ. Barker D. Brimble MA. Synlett  2005,  1809 

<A NAME="RD27908ST-3B">3b</A> Doisy X. Blagbrough IS. Wonnacott S. Potter BVL. Pharm. Pharmacol. Commun.  1998,  4:  313 

<A NAME="RD27908ST-3C">3c</A> Bergmeier SC. Lapinsky DJ. Free RB. McKay DB. Bioorg. Med. Chem. Lett.  1999,  9:  2263 

<A NAME="RD27908ST-3D">3d</A> Bryant DL. Free RB. Thomasy SM. Lapinsky DJ. Ismail KA. Arason KM. Bergmeier SC. McKay DB. Ann. N. Y. Acad. Sci.  2002,  971:  139 

<A NAME="RD27908ST-3E">3e</A> Bryant DL. Free RB. Thomasy SM. Lapinsky DJ. Ismail KA. McKay SB. Bergmeier SC. McKay DB. Neurosci. Res.  2002,  42:  57 

<A NAME="RD27908ST-3F">3f</A> Bergmeier SC. Ismail KA. Arason KM. McKay S. Bryant DL. McKay DB. Bioorg. Med. Chem. Lett.  2004,  14:  3739 

<A NAME="RD27908ST-3G">3g</A> Ismail KA. Bergmeier SC. Eur. J. Med. Chem.  2002,  469 

<A NAME="RD27908ST-3H">3h</A> Simoni D. Rossi M. Rondanin R. Baruchello R. Grisolia G. Eleopra M. Giovannini R. Bozzoli A. Davalli S. Di Fabio R. Donati D. Tetrahedron Lett.  2005,  46:  759 

<A NAME="RD27908ST-3I">3i</A> Huang J. Orac CM. McKay S. McKay DB. Bergmeier SC. Bioorg. Med. Chem.  2008,  16:  3816 

<A NAME="RD27908ST-4">4</A> Fustero S. Jimenez D. Moscardo J. Catalan S. del Pozo C. Org. Lett.  2007,  9:  5283 

<A NAME="RD27908ST-5A">5a</A> Murty MSR. Ram R. Yadav JS. Tetrahedron Lett.  2008,  49:  1141 

<A NAME="RD27908ST-5B">5b</A> Dobbs AP. Guesne SJJ. Synlett  2005,  2101 

<A NAME="RD27908ST-5C">5c</A> Carballo RM. Ramirez MA. Rodriguez ML. Martin VS. Padron JI. Org. Lett.  2006,  8:  3837 

<A NAME="RD27908ST-6">6</A> Sales M. Charette AB. Org. Lett.  2005,  7:  5773 

<A NAME="RD27908ST-7">7</A> Brimble MA. Brocke C. Eur. J. Org. Chem.  2005,  2385 

<A NAME="RD27908ST-8">8</A> Halliday JI. Chebib M. Turner P. McLeod MD. Org. Lett.  2006,  8:  3399 

<A NAME="RD27908ST-9A">9a</A> Kuthan J. Palecek J. Collect. Czech. Chem. Commun.  1963,  28:  2260 

<A NAME="RD27908ST-9B">9b</A> Calabrese AA, Fradet DS, Hepworth D, and Lansdell M. inventors; US  20050176772. 

<A NAME="RD27908ST-10">10</A> Davis JM. Truong A. Hamilton AD. Org. Lett.  2005,  7:  5405 

<A NAME="RD27908ST-11A">11a</A> Howton D. J. Org. Chem.  1945,  10:  277 

<A NAME="RD27908ST-11B">11b</A> McElvain SM. J. Am. Chem. Soc.  1926,  48:  2179 

<A NAME="RD27908ST-12A">12a</A> Dodd DS. Oehlschlager AC. Tetrahedron Lett.  1991,  32:  3643 

<A NAME="RD27908ST-12B">12b</A> Khartulyari AS. Maier MM. Eur. J. Org. Chem.  2007,  317 

<A NAME="RD27908ST-12C">12c</A> Langiois Y. Potier R. Tetrahedron  1975,  31:  423 

<A NAME="RD27908ST-13">13</A> Yoshizawa K. Toyota S. Toda F. Tetrahedron Lett.  2001,  42:  7983 

<A NAME="RD27908ST-14">14</A> Huckin SN. Weiler L. J. Am. Chem. Soc.  1974,  96:  1082 

<A NAME="RD27908ST-15">15</A> Misaki T. Nagase R. Matsumoto K. Tanabe Y. J. Am. Chem. Soc.  2005,  127:  2854 

<A NAME="RD27908ST-16A">16a</A> Kiguchi T. Hashimoto C. Naito T. Ninomiya I. Heterocycles  1982,  19:  2279 

<A NAME="RD27908ST-16B">16b</A> Horii Z. Watanabe T. Kurihara T. Tamura Y. Chem. Pharm. Bull.  1965,  13:  420 

<A NAME="RD27908ST-16C">16c</A> Ninomyia I. Hashimoto C. Kiguchi T. Naito T.
J. Chem. Soc., Perkin Trans. 1  1985,  941 

<A NAME="RD27908ST-17A">17a</A> Simonsen KB. Ayida BK. Vourloumis D. Winters GC. Takahashi M. Shandrick S. Zhao Q. Hermann T. ChemBioChem  2003,  4:  886 

<A NAME="RD27908ST-17B">17b</A> Bach P. Lohse A. Bols M. Tetrahedron Lett.  1999,  40:  367 

<A NAME="RD27908ST-17C">17c</A> Liang X. Petersen BO. Duus J. Bols M. J. Chem. Soc., Perkin Trans. 1  2001,  2764 

<A NAME="RD27908ST-18">18</A> Beeson C. Pham N. Dix TA. Tetrahedron Lett.  1992,  43:  2925 

<A NAME="RD27908ST-19">19</A>

General Procedure for the Synthesis of 4-Piperidones 5 Methyltrichlorosilane (1.5 mmol) was added dropwise to a mixture of β-keto ester 4 (1 mmol) and bisaminol ether 3 (1.2 mmol) in dry MeCN (3 mL) then stirred at r.t. for 20 h. The reaction was then quenched with aq sat. NaHCO₃ until basic, extracted with EtOAc (3 × 3 mL), dried (MgSO₄), and concentrated in vacuo to give the crude product, which was purified by flash chromatography to afford the 4-piperidones 5 in 51-90% yields.
General Procedure for the Synthesis of 4-Piperidols 6 A solution of piperidone 5 (1 mmol) in THF (4 mL) was added to a solution of NaBH₄ (0.5 mmol) in THF (4 mL) and deionized H₂O (4 mL). The mixture was stirred for 30 min at 0 ˚C, then stirred for 3 h at r.t. The reaction was quenched with 2 M NaOH and extracted with Et₂O (3 × 10 mL). The combined organic extracts were washed with brine, dried (MgSO₄), and concentrated in vacuo to give the crude product, which was purified by flash chromatography to afford the 4-piperidol 6.
Spectral Data for Selected ProductsEthyl (3 R *,5 R *)-1-Butyl-3,5-dimethyl-4-oxopiperidine-3-carboxylate (5e) ^¹H NMR (300 MHz, CDCl₃): δ = 0.90 (3 H, t, J = 7.2 Hz, NCH₂CH₂CH₂CH ₃), 1.00 (3 H, d, J = 6.5 Hz, 5-CH₃), 1.20 (3 H, s, 3-CH₃), 1.23 (3 H, t, J = 6.0 Hz, OCH₂CH ₃), 1.28-1.39 (2 H, m, NCH₂CH₂CH ₂CH₃), 1.41-1.51 (2 H, m, NCH₂CH ₂CH₂CH₃), 1.95 (1 H, d, J = 11.5 Hz, 2_A-H), 1.97 (1 H, dd, J = 10.9, 10.9 Hz, 6_A-H), 2.26-2.47 (2 H, m, NCH ₂CH₂CH₂CH₃), 2.89-3.01 (1 H, m, 5-H), 3.03-3.10 (1 H, m, 6_B-H), 3.54 (1 H, dd, J = 11.5, 3.1 Hz, 2_B-H), 4.17 (2 H, q, J = 7.11 Hz, OCH ₂CH₃). ^¹³C NMR (75 MHz, CDCl₃): δ = 11.6 (CH₃, 5-CH₃), 13.9 [CH₃, N(CH₂)₃ CH₃], 14.0 (CH₃, OCH₂ CH₃), 17.9 (CH₃, 3-CH₃), 20.4 (CH₂, NCH₂CH₂ CH₂CH₃), 29.2 (CH₂, NCH₂ CH₂CH₂CH₃), 43.2 (CH, C-5), 56.8 (CH₂, NCH₂CH₂CH₂CH₃), 56.8 (q, C-3), 61.2 (CH₂, OCH₂CH₃), 62.2 (CH₂, C-6), 63.2 (CH₂, C-2), 173.1 (q, COO), 208.1 (q, C-4).
Ethyl (3 R *,5 R *)-1-Butyl-5-ethyl-3-methyl-4-oxopiperi-dine-3-carboxylate (5f) ^¹H NMR (400 MHz, CDCl₃): δ = 0.88-0.95 (6 H, m,
5-CH₂CH ₃, NCH₂CH₂CH₂CH ₃), 1.12-1.19 (1 H, m, 1 ×  5-CH₂CH ₃), 1.21 (3 H, s, 3-CH₃), 1.24-1.29 (3 H, m, OCH₂CH ₃), 1.31-1.38 (2 H, m, NCH₂CH₂CH ₂CH₃), 1.45-1.53 (2 H, m, NCH₂CH ₂CH₂CH₃), 1.86 (1 H, p, J = 5.4 Hz, 1 × 5-CH ₂CH₃), 1.95 (1 H, dd, J = 8.6, 1.0 Hz, 2_A-H), 1.98 (1 H, dd, J = 11.0, 8.5 Hz, 6_A-H), 2.29-2.50 (2 H, m, NCH ₂CH₂CH₂CH₃), 2.73-2.81 (1 H, m, 5-H), 3.10-3.15 (1 H, m, 6_B-H), 3.57 (1 H, dd, J = 8.6, 2.2 Hz, 2_B-H), 4.15-4.25 (2 H, m, OCH ₂CH₃). ^¹³C NMR (100 MHz, CDCl₃): δ = 11.6 (CH₃, 5-CH₂ CH₃), 13.9 (2 × CH₃, OCH₂ CH₃, NCH₂CH₂CH₂ CH₃), 17.8 (CH₃, 3-CH₃), 19.7 (CH₂,
5-CH₂CH₃), 20.4 (CH₂, NCH₂CH₂ CH₂CH₃), 29.2 (CH₂, NCH₂ CH₂CH₂CH₃), 50.1 (CH, C-5), 56.8 (q, C-3), 56.9 (CH₂, NCH₂CH₂CH₂CH₃), 60.4 (CH₂, C-6), 61.1 (OCH₂CH₃), 63.0 (CH₂, C-2), 173.0 (q, COO), 207.62
(q, C-4).
Ethyl 1-Butyl-3,5,5-trimethyl-4-oxopiperidine-3-carboxylate (5h) ^¹H NMR (300 MHz, CDCl₃): δ = 0.85 (3 H, t, J = 7.2 Hz, NCH₂CH₂CH₂CH ₃), 1.03 and 1.05 [2 × 3 H, d, J = 6.7 Hz,
5-(CH₃)₂], 1.24 (3 H, t, J = 7.1 Hz, OCH₂CH ₃), 1.22-1.40 (4 H, m, NCH₂CH ₂CH₂CH₃, NCH₂CH₂CH ₂CH₃), 1.38 (3 H, s, 3-CH₃), 2.53 (2 H, t, J = 6.9 Hz, NCH ₂CH₂CH₂CH₃), 2.86 (2 H, d, J = 6.7 Hz, 6-H), 2.91 (2 H, d, J = 1.5 Hz, 2-H), 4.16 (2 H, q, J = 10.7 Hz, OCH ₂CH₃). ^¹³C NMR (75 MHz, CDCl₃): δ = 13.9 (CH₃, NCH₂CH₂CH₂ CH₃), 14.0 (CH₃, OCH₂ CH₃), 18.4 (CH₃, 3-CH₃), 19.9 [CH₃, 1 × 5-(CH₃)₂], 20.1 (q, C-3), 20.2 (CH₂, NCH₂CH₂ CH₂CH₃), 20.3 [CH₃, 1 × 5-(CH₃)₂], 32.0 (CH₂, NCH₂ CH₂CH₂CH₃), 37.0 (CH₂, C-6), 50.2 (CH₂, NCH₂CH₂CH₂CH₃), 54.2 (q, C-5), 54.2 (CH₂, C-2), 61.1 (CH₂, OCH₂CH₃), 172.7 (q, COO), 212.9 (q, C-4).
Ethyl (3 R *,4 S *,5 R *)-1-Butyl-3,5-dimethyl-4-hydroxy-piperidine-3-carboxylate (6b) ^¹H NMR (300 MHz, CDCl₃): δ = 0.86 (3 H, t, J = 7.1 Hz, NCH₂CH₂CH₂CH ₃), 0.97 (3 H, d, J = 6.5 Hz, 5-CH₃), 1.22-1.28 (8H, m, 3-CH₃, OCH₂CH ₃, NCH₂CH₂CH ₂CH₃), 1.30-1.44 (2 H, m, NCH₂CH ₂CH₂CH₃), 1.61 (1 H, d, J = 11.5 Hz, 2_A-H), 1.64 (1 H, t, J = 11.1, 6_A-H), 1.90-2.01 (1 H, m, 5-H), 2.08-2.31 (2 H, m, NCH ₂CH₂CH₂CH₃), 2.69 (1 H, t, J = 11.2 Hz, 4-H), 2.73-2.79 (1 H, m, 6_B-H), 3.26 (1 H, dd, J = 11.5, 5.2 Hz, 2_B-H), 3.36 (1 H, d, J = 11.8 Hz, OH), 4.14 (2 H, q, J = 7.1 Hz, OCH ₂CH₃). ^¹³C NMR (75 MHz, CDCl₃): δ = 13.9 (CH₃, NCH₂CH₂CH₂ CH₃), 14.0 (CH₃, OCH₂ CH₃), 20.4 (CH₂, NCH₂CH₂ CH₂CH₃), 21.3 (CH₃, 3-CH₃), 29.2 (CH₂, NCH₂ CH₂CH₂CH₃), 36.3 (CH, C-5), 47.9 (q, C-3), 57.4 (CH₂, NCH₂CH₂CH₂CH₃), 60.4 (CH₂, OCH₂CH₃), 61.7 (CH₂, C-6), 62.1 (CH₂, C-2), 81.9 (CH, C-4), 177.4 (q, COO).
Ethyl (3 R *,4 S *,5 R *)-1-Butyl-4-hydroxy-5-isopropyl-3-methylpiperidine-3-carboxylate (6d) ^¹H NMR (300 MHz, CDCl₃): δ = 0.83 [3 H, d, J = 7.1 Hz, 1 × CH(CH ₃)₂], 0.87 (3 H, t, J = 7.2 Hz, NCH₂CH₂CH₂CH ₃), 0.88-0.97 (2 H, m, NCH₂CH₂CH ₂CH₃), 0.93 [3 H, d, J = 7.2 Hz, 1 × CH(CH ₃)₂], 1.25 (3 H, t, J = 7.1 Hz, OCH₂CH ₃), 1.26 (3 H, s, 3-CH₃), 1.32-1.45 (2 H, m, NCH₂CH ₂CH₂CH₃), 1.54 (1 H, d, J = 11.5 Hz, 2_A-H), 1.70 (1 H, d, J = 11.3 Hz, 6_A-H), 1.79-1.88 (1 H, m, 5-H), 2.03-2.34 [3H, m, CH(CH₃)₂, NCH ₂CH₂CH₂CH₃], 2.70-2.75 (1 H, m, 6_B-H), 3.00 (1 H, d, J = 10.5 Hz, 4-H), 3.26 (1 H, dd, J = 12.3, 3.3 Hz, 2_B-H), 3.72-3.74 (1 H, m, OH), 4.14 (2 H, qd, J = 7.1, 1.7 Hz, OCH ₂CH₃). ^¹³C NMR (100 MHz, CDCl₃): δ = 14.0 (2 × CH₃, OCH₂ CH₃, NCH₂CH₂CH₂ CH₃), 16.8 [CH₃, 1 × CH(CH₃)₂], 20.5 (CH₂, NCH₂CH₂ CH₂CH₃), 20.9 (CH₃, 3-CH₃), 21.5 [CH₃, 1 × CH(CH₃)₂], 25.6 [CH, CH(CH₃)₂], 29.2 (CH₂, NCH₂ CH₂CH₂CH₃), 45.6 (CH, C-5), 47.8 (q, C-3), 54.4 (CH₂, C-6), 57.8 (CH₂, NCH₂CH₂CH₂CH₃), 60.4 (CH₂, OCH₂CH₃), 61.7 (CH₂,
C-2), 77.6 (CH, C-4), 177.5 (q, COO).
Ethyl (3 R *,4 S *)-1-Butyl-4-hydroxy-3,5,5-trimethyl-piperidine-3-carboxylate and Ethyl (3 R *,4 R *)-1-Butyl-4-hydroxy-3,5,5-trimethylpiperidine-3-carboxylate (6e) ^¹H NMR (300 MHz, CDCl₃): δ (* denotes signals from the second diastereomer) = 0.82-0.96 [18 H, m, 2 × C(CH ₃)₂, 2 × C(CH ₃)₂*, NCH₂CH₂CH₂CH ₃, NCH₂CH₂CH₂CH ₃*], 1.08 (3 H, s, 3-CH₃*), 1.20 (3 H, s, 3-CH₃), 1.23 (3 H, t, J = 7.13 Hz, OCH₂CH ₃), 1.24 (3 H, t, J = 6.3 Hz, OCH₂CH ₃*), 1.28-1.34 (2 × 2H, m, NCH₂CH₂CH ₂CH₃, NCH₂CH₂CH ₂CH₃*), 1.35-1.43 (4 H, m, NCH₂CH ₂CH₂CH₃, NCH₂CH ₂CH₂CH₃*), 2.58-2.48 (4 H, m, NCH ₂CH₂CH₂CH₃, NCH ₂CH₂CH₂CH₃*), 2.64 (1 H, d, J = 10.5 Hz, 6-H*), 2.78 (1 H, d, J = 12.4 Hz, 6-H), 2.97
(2 H, d, J = 9.8 Hz, 2-H*), 3.01 (2 H, d, J = 8.13 Hz, 2-H), 3.49 (1 H, d, J = 4.0 Hz, 4-H*), 3.81 (1 H, d, J = 5.5 Hz,
4-H), 4.06-4.16 (6 H, m, OCH ₂CH₃, OCH ₂CH₃*, OH, OH*). ^¹³C NMR (75 MHz, CDCl₃): δ (* denotes signals from the second diastereomer) = 13.8-14.1 (4 × CH₃, OCH₂ CH₃, OCH₂ CH₃*, NCH₂CH₂CH₂ CH₃, NCH₂CH₂CH₂ CH₃*), 16.8 (CH₃, 3-CH₃*), 16.9 [CH₃, 1 × 
5-(CH₃)₂*], 18.5 [CH₃, 1 × 5-(CH₃)₂], 20.2 (CH₃, NCH₂CH₂ CH₂CH₃*), 20.36 (CH₃, 3-CH₃), 21.32 [CH₃, 1 × 5-(CH₃)₂*], 21.99 [CH₃, 1 × 5-(CH₃)₂], 29.61 (q, C-3*), 30.91 (q, C-3), 31.78 (CH₂, NCH₂ CH₂CH₂CH₃*), 31.85 (CH₂, NCH₂ CH₂CH₂CH₃), 48.74 (q, C-5*), 49.68 (CH₂, NCH₂CH₂CH₂CH₃*), 49.98 (q, C-5), 50.07 (CH₂, NCH₂CH₂CH₂CH₃), 56.30 (2 × CH₂, C-2*, C-6*), 56.66 (2 × CH₂, C-2, C-6), 60.46 (CH₂, OCH₂CH₃*), 60.57 (CH₂, OCH₂CH₃), 80.95 (CH, C-4*), 82.27 (CH, C-4), 175.91 (q, COO*), 176.32 (q, COO).
(3 S *,4 S *,5 R *)-(1-Butyl-5-ethyl-4-hydroxy-3-methylpiperidin-3-yl)methanol (7) ^¹H NMR (300 MHz, CDCl₃): δ = 0.84 (3 H, s, 3-CH₃), 0.87 (3 H, t, J = 7.2 Hz, 5-CH₂CH ₃), 0.94 (3 H, d, J = 6.4 Hz, NCH₂CH₂CH₂CH ₃), 1.22-1.34 (4 H, m, 5-CH ₂CH₃, NCH₂CH₂CH ₂CH₃), 1.37-1.44 (2 H, m, NCH₂CH ₂CH₂CH₃), 1.57 (1 H, t, J = 11.4 Hz, 6_A-H), 1.91
(1 H, dd, J = 11.9, 1.9 Hz, 2_A-H), 2.20 (2 H, td, J = 14.4, 2.0 Hz, NCH ₂CH₂CH₂CH₃), 2.28-2.40 (1 H, m, 5-H), 2.53 (1 H, m, 4-H), 2.79-2.84 (2 H, m, 2_B-H, 6_B-H), 3.52 (1 H, br,
4-OH), 3.60 (1 H, d, J = 10.8 Hz, 1 × CH _AOH), 3.81 (1 H, dd, J = 10.8, 1.9 Hz, 1 × CH _BOH), 5.48 (1 H, s, CH₂OH). ^¹³C NMR (75 MHz, CDCl₃): δ = 13.9 (CH₃, NCH₂CH₂CH₂ CH₃), 16.8 (CH₃, 5-CH₂ CH₃), 20.5 (CH₂, NCH₂CH₂ CH₂CH₃), 22.5 (CH₃, 3-CH₃), 29.1 (CH₂, NCH₂ CH₂CH₂CH₃), 29.7 (CH₂, 5-CH₂CH₃), 35.2 (CH, C-5), 39.7 (q, C-3), 57.5 (CH₂, NCH₂CH₂CH₂CH₃), 60.7 (CH₂, C-6), 64.7 (CH₂, C-2), 68.9 (CH₂, CH₂OH), 87.0 (CH, C-4).